Brand profile
Celgene Corporation (Otezla)
@celgenecorporationotezla
Otezla (apremilast) is an oral treatment for plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet's disease. Developed by Celgene, it was divested to Amgen in 2019 as a condition of Bristol Myers Squibb's acquisition of Celgene, and is now marketed by Amgen.
Pharmaceuticals
Mentioned this brand
Trendsetters who list this brand under brands they've worked with.
Run your next campaign like Celgene Corporation (Otezla)
Register your brand to brief creators, agree terms and pay for the campaign in one place.
Similar Brands
Other brands with overlapping categories you may want to explore.
